Quantessence Capital’s AdaptHealth AHCO Stock Holding History

Quantessence Capital’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,600	Closed	-$332K	–	191
2025 Q1	$332K	Buy	+30,600	New	+$308K	0.08%	225

Other funds holding AHCO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Quantessence Capital's AHCO Position: Q2 2025 in Review

Quantessence Capital sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 30,600 shares — an estimated $332K sold.

Quantessence Capital first reported a position in AHCO in Q1 2025 and held it in 1 quarter. The position peaked at $332K in Q1 2025. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

Quantessence Capital reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
Quantessence Capital sold 30,600 AdaptHealth shares in Q2 2025, an estimated $332K.
Quantessence Capital first reported a position in AdaptHealth in Q1 2025 and held it in 1 quarter.
Quantessence Capital's AdaptHealth position peaked at $332K in Q1 2025.
218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Quantessence Capital's 13F filing for Q2 2025, filed 14 Aug 2025.